Valuation: Steris PLC

Market Cap 20.33B 18.07B 16.85B 15.35B 28.98B 1,958B 29.23B 204B 79.17B 998B 76.33B 74.68B 3,210B P/E 2027 *
22.5x
P/E 2028 * 19.9x
Enterprise Value 21.69B 19.27B 17.97B 16.38B 30.91B 2,089B 31.18B 218B 84.45B 1,065B 81.42B 79.66B 3,424B EV / Sales 2027 *
3.4x
EV / Sales 2028 * 3.15x
Free-Float
99.69%
Yield 2027 *
1.28%
Yield 2028 * 1.38%
Manager TitleAgeSince
Chief Executive Officer 53 28/07/2021
Director of Finance/CFO 59 17/08/2025
Compliance Officer - 31/07/2019
Director TitleAgeSince
Director/Board Member 73 28/02/2005
Director/Board Member 54 30/04/2018
Chairman 67 27/07/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+3.19% - - 20.33B
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.13%-0.86%-10.95%+13.69% 76.69B
Weighted average by Cap. +0.05%-1.30%-17.07%+11.23%

Financials

2027 *2028 *
Net sales 6.37B 5.66B 5.28B 4.81B 9.08B 614B 9.16B 63.99B 24.81B 313B 23.92B 23.4B 1,006B 6.78B 6.02B 5.62B 5.12B 9.66B 653B 9.74B 68.06B 26.39B 333B 25.44B 24.89B 1,070B
Net income 889M 790M 737M 671M 1.27B 85.59B 1.28B 8.93B 3.46B 43.64B 3.34B 3.26B 140B 1.02B 906M 845M 770M 1.45B 98.14B 1.47B 10.23B 3.97B 50.04B 3.83B 3.74B 161B
Net Debt 1.36B 1.21B 1.12B 1.02B 1.93B 131B 1.95B 13.62B 5.28B 66.58B 5.09B 4.98B 214B 1.02B 907M 846M 771M 1.46B 98.33B 1.47B 10.25B 3.98B 50.13B 3.83B 3.75B 161B
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-